Cargando…
Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk
In order to explore the optimal timing for initiating cytoreduction chemotherapy following all-trans retinoic acid plus arsenic trioxide administration, 58 newly diagnosed patients with acute promyelocytic leukemia (APL) with low-intermediate mortality risk were retrospectively analyzed. During indu...
Autores principales: | Wen, Jingjing, Xu, Fang, Zhou, Qiaolin, Hu, Hong, Liu, Yiping, Su, Jing, Zhang, Ya, Qu, Wen, Shi, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060852/ https://www.ncbi.nlm.nih.gov/pubmed/33903818 http://dx.doi.org/10.3892/mco.2021.2274 |
Ejemplares similares
-
Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia
por: Wen, Jingjing, et al.
Publicado: (2022) -
Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia
por: Wen, Jingjing, et al.
Publicado: (2023) -
Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
por: Sun, Jianai, et al.
Publicado: (2020) -
Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011) -
A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review
por: Liu, Yiping, et al.
Publicado: (2019)